Sanofi India Managing Director Rajaram Narayanan resigns

Mumbai: Sanofi India Limited has announced that its Board of Directors have accepted the resignation of its Managing Director, Rajaram Narayanan, effective close of business hours on April 10, 2022.

Rajaram has decided to pursue an opportunity outside of Sanofi. His successor will be appointed in due course. Rajaram joined the company in 2014 as General Manager and was later elevated as Country Lead & Managing Director. In these roles, he has led the strategic reorientation of the organisation, sharpening its focus on core areas, developing new business models, building future talent and driving digital transformation across all areas of the business.

The Company also took significant steps to streamline its portfolio, supply footprint and go-to-market operations. He leaves behind a strong leadership team to steer the Company forward. During Rajaram's tenure as Managing Director of Sanofi India, the Company has been recognised as a Top Employer for three consecutive years and has also received several recognitions for its initiatives in HR practices, Communications, CSR (Corporate Social Responsibility) and public health. Sanofi India has become an important source of talent for the Sanofi Group, with several employees growing to take on various global roles.

Said Aditya Narayan, Chairman of the Board, SIL India, "Under Rajaram's leadership Sanofi India has successfully implemented a variety of transformational initiatives to deliver market beating growth in key therapies and significantly improve its overall financials. On behalf of the Board, I thank him for his splendid contribution and wish him the very best in his future endeavours."

Speaking on his move, Rajaram Narayanan, Managing Director – Sanofi India Limited said, "I am fortunate to have been part of this wonderful organisation, and its transformational journey over these years. I am grateful to the Board of Directors, the leadership team and all the employees of Sanofi for helping build one of the most admired companies in healthcare. Today, the company is well placed to grow and make a real difference to patients through its focussed portfolio, digital solutions, and of course an outstanding pool of talent. Sanofi has always had a tremendous impact on the people who associate with it. It goes without saying, that I take the company and my team with me in my heart, and will be rooting for Sanofi, wherever I am in the future."

Read also: Sanofi partners with AI firm Exscientia to develop up to 15 new drugs